Galmed Pharmaceuticals
GLMD
GLMD
19 hedge funds and large institutions have $14.8M invested in Galmed Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$395K |
2 |
Renaissance Technologies
New York
|
+$290K |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$248K |
4 |
UBS Group
Zurich,
Switzerland
|
+$219K |
5 |
Morgan Stanley
New York
|
+$200K |